References for Supratentorial Pleomorphic Xanthoastrocytomas in Children

  1. Kepes JJ, Rubinstein LJ, Eng LF: Pleomorphic xanthoastrocytoma: a distinctive meningocerebral glioma of young subjects with relatively favorable prognosis. A study of 12 cases. Cancer 44:1839-1852, 1979
  2. Giannini CPW, Louis DN, Liberski P: Pleomorphic xanthoastrocytoma, in Louis DN, Wiestler OD, Cavenee WK (eds): WHO Classification of Tumors of the Central Nervous System. Geneva: World Health Organization, 2007, pp 22-24
  3. Nageswara Rao AA, Laack NN, Giannini C, et al: Pleomorphic xanthoastrocytoma in children and adolescents. Pediatr Blood Cancer 55:290-294, 2010
  4. Pahapill PA, Ramsay DA, Del Maestro RF: Pleomorphic xanthoastrocytoma: case report and analysis of the literature concerning the efficacy of resection and the significance of necrosis. Neurosurgery 38:822-828, 1996
  5. Crespo-Rodriguez AM, Smirniotopoulos JG, Rushing EJ: MR and CT imaging of 24 pleomorphic xanthoastrocytomas (PXA) and a review of the literature. Neuroradiology 49:307-315, 2007
  6. Kubo O, Sasahara A, Tajika Y, et al: Pleomorphic xanthoastrocytoma with neurofibromatosis type 1: case report. Noshuyo Byori 13:79-83, 1996
  7. Lach B, Duggal N, DaSilva VF, et al: Association of pleomorphic xanthoastrocytoma with cortical dysplasia and neuronal tumors. A report of 3 cases. Cancer 78:2551-2563, 1996
  8. Kim B, Chung CK, Myung JK, et al : Pleomorphic xanthoastrocytoma associated with long-standing Taylor-type IIB-focal cortical dysplasia in an adult. Pathol Res Pract 205:113-117, 2009
  9. Zakrzewska M, Szybka M, Biernat W, et al: Prevalence of mutated TP53 on cDNA (but not on DNA template) in pleomorphic xanthoastrocytoma with positive TP53 immunohistochemistry. Cancer Genet Cytogenet 193:93-97, 2009
  10. Grau E, Balaguer J, Canete A, et al: Subtelomeric analysis of pediatric astrocytomas: subchromosomal instability is a distinctive feature of pleomorphic xanthoastrocytoma. J Neurooncol 93:175-182, 2009
  11. Giannini C, Hebrink D, Scheithauer BW, et al: Analysis of p53 mutation and expression in pleomorphic xanthoastrocytoma. Neurogenetics 3:159-162, 2001
  12. Hirose T, Ishizawa K, Sugiyama K, et al: Pleomorphic xanthoastrocytoma: a comparative pathological study between conventional and anaplastic types. Histopathology 52:183-193, 2008
  13. Giannini C, Scheithauer BW, Burger PC, et al: Pleomorphic xanthoastrocytomas: What do we really know about it? Cancer 85:2033-2045, 1999
  14. Hamlat A, Le Strat A, Guegan Y, et al: Cerebellar pleomorphic xanthoastrocytoma: case report and literature review Surg Neurol 68:89-95, 2007
  15. Hanif G, Shafqat S: Morphological pattern and frequency of intracranial tumours in children. J Coll Physicians Surg Pak 14:150-152, 2004
  16. Fouladi M, Jenkins J, Burger P, et al: Pleomorphic xanthoastrocytoma: Favorable outcome after complete surgical resection. Neuro-Oncology 3:184-192, 2001
  17. Fernandez D, Muranjan MN, Bavdekar SB, et al: Pleomorphic xanthoasrocytoma. Indian Pediatrics 38:297-300, 2001
  18. Lien RD, Cardenas CA, Rajagopalan S: Pleomorphic xanthoastrocytoma of the brain: MR findings in six patients. Am J Roentgenol 159:1287-1290, 1992
  19. Perkins SM, Mitra N, Fei W, et al: Patterns of care and outcomes of patients with pleomorphic xanthoastrocytoma: a SEER analysis. J Neurooncol 110:99-104, 2012
  20. Ng  WH, Lim T, Yeo TT: Pleomorphic xanthoastrocytoma in elderly patients may portend a poor prognosis. J Clin Neurosci 15:476-478, 2008
  21. Michael M, Etzl JR: Positron emission tomography in three children with pleomorphic xanthoastrocytoma. J Child Neurol 7:522-527, 2002
  22. Macaulay RJ, Jay V, Hoffman HJ, et al: Increased mitotic activity as a negative prognostic indicator in pleomorphic xanthoastrocytoma. Case report. J Neurosurg 79:761-768, 1993
  23. Cartmill M, Hewitt M, Walker D, et al: The use of chemotherapy to facilitate surgical resection in pleomorphic xanthoastrocytoma. Experience in a single case. Childs Nerv Syst 17:563-566, 2001
  24. Thomas C, Golden B: Pleomorphic xanthoastrocytoma: report of two cases and brief review of the literature. Clin Neuropathol 12:97-101, 1993
  25. Bicik I, Raman R, Knightly JJ: PET-FDG of pleomorphic xanthoastrocytoma. J Nucl Med 36:97-99, 1995
  26. Tsuyuguchi N: Evaluation of pleomorphic xanthoastrocytoma by use of positron emission tomography with [18-F]-fluorodeoxyglucose and [11C]-methionine tracers. AJNR 22:311-313, 2001
  27. Koeller KK, Rushing EJ: From the archives of the AFIP: pilocytic astrocytoma: radiologic-pathologic correlation. Radiographics 24:1693-708, 2004
  28. Marton E, Feletti A, Orvieto E, et al: Malignant progression in pleomorphic xanthoastrocytoma: personal experience and review of the literature. J Neurol Sci 252:144-153, 2007
  29. Dias-Santagata D, Lam Q, Vernovsky K, et al: BRAF V600E mutations are common in pleomorphic xanthoastrocytoma: diagnostic and therapeutic implications. PLoS One 29;6:e17948, 2011
  30. Giannini C, Scheithauer BW: Classification and grading of low-grade astrocytic tumors in children. Brain Pathol 7:785–798, 1997
  31. Paulus W, Lisle DK, Tonn JC, et al: Molecular genetic alterations in pleomorphic xanthoastrocytoma. Acta Neuropathol 91:293–297, 1996
  32. Charbel FT: Pleomorphic xanthoastrocytoma with malignant progression. Surg Neurol 50:385–386, 1998
  33. Dickerman RD: Diffuse malignant transformation of pleomorphic xanthoastrocytoma 21 years later: a matter of time? Acta Neurochirurgica, 148: 95-97, 2006
  34. Nakajima T: Malignant transformation of pleomorphic xanthoastrocytoma. Acta Neurochirurgica 148:67-71, 2006